Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-05-13 to 2025-05-14
Current total value of award: $215.9
Description: 4568228649!TRANEXAMIC 1,000 MG/100ML-NACL 100ML